Q1 2025 EPS Estimates for Encompass Health Co. (NYSE:EHC) Lifted by Analyst

Encompass Health Co. (NYSE:EHC) – Research analysts at William Blair lifted their Q1 2025 EPS estimates for shares of Encompass Health in a research note issued on Wednesday, April 24th. William Blair analyst J. Haase now expects that the company will post earnings of $1.30 per share for the quarter, up from their prior estimate of $1.03. William Blair currently has a “Outperform” rating on the stock. The consensus estimate for Encompass Health’s current full-year earnings is $4.10 per share.

A number of other equities research analysts also recently issued reports on the stock. Mizuho upped their price target on shares of Encompass Health from $93.00 to $95.00 and gave the company a “buy” rating in a research note on Thursday, April 25th. Raymond James restated a “strong-buy” rating and set a $95.00 price target (up previously from $85.00) on shares of Encompass Health in a report on Friday. Barclays boosted their price objective on shares of Encompass Health from $101.00 to $108.00 and gave the company an “overweight” rating in a research report on Thursday, April 25th. Stephens reiterated an “overweight” rating and set a $85.00 price target on shares of Encompass Health in a report on Tuesday, January 16th. Finally, Truist Financial boosted their target price on Encompass Health from $82.00 to $86.00 and gave the company a “buy” rating in a research report on Friday, February 9th. Eight equities research analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. According to MarketBeat, Encompass Health presently has a consensus rating of “Buy” and an average price target of $88.13.

Encompass Health Price Performance

Shares of Encompass Health stock opened at $83.62 on Monday. The firm has a market cap of $8.37 billion, a PE ratio of 22.60, a PEG ratio of 1.34 and a beta of 0.94. Encompass Health has a 12 month low of $57.55 and a 12 month high of $85.84. The stock has a 50 day moving average of $78.45 and a 200 day moving average of $71.10. The company has a current ratio of 1.37, a quick ratio of 1.28 and a debt-to-equity ratio of 1.14.

Encompass Health (NYSE:EHC) last posted its quarterly earnings results on Wednesday, April 24th. The company reported $1.12 earnings per share for the quarter, topping the consensus estimate of $0.93 by $0.19. Encompass Health had a return on equity of 18.01% and a net margin of 7.60%. The business had revenue of $1.32 billion during the quarter, compared to the consensus estimate of $1.27 billion. During the same period in the prior year, the company posted $0.88 EPS. The firm’s revenue for the quarter was up 13.4% compared to the same quarter last year.

Hedge Funds Weigh In On Encompass Health

Several institutional investors have recently bought and sold shares of the business. Principal Securities Inc. purchased a new stake in shares of Encompass Health during the fourth quarter valued at about $25,000. Benjamin F. Edwards & Company Inc. lifted its holdings in shares of Encompass Health by 360.2% during the 4th quarter. Benjamin F. Edwards & Company Inc. now owns 405 shares of the company’s stock valued at $27,000 after purchasing an additional 317 shares during the last quarter. McGlone Suttner Wealth Management Inc. purchased a new position in Encompass Health during the 4th quarter worth $30,000. GAMMA Investing LLC acquired a new position in Encompass Health during the 4th quarter valued at about $33,000. Finally, C M Bidwell & Associates Ltd. purchased a new stake in Encompass Health in the third quarter valued at about $35,000. 97.25% of the stock is owned by hedge funds and other institutional investors.

Encompass Health Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Monday, April 15th. Investors of record on Monday, April 1st were paid a $0.15 dividend. This represents a $0.60 dividend on an annualized basis and a yield of 0.72%. The ex-dividend date of this dividend was Thursday, March 28th. Encompass Health’s dividend payout ratio (DPR) is presently 16.22%.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.